Cargando…

Merits of Level III Axillary Dissection in Node-Positive Breast Cancer: A Prospective, Single-Institution Study From India

PURPOSE: A complete axillary lymph node (ALN) dissection is therapeutic in node-positive breast cancer. Presently, there is no international consensus regarding anatomic levels to be addressed in complete axillary dissection. We assessed the burden of disease in level III axilla. MATERIALS AND METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joshi, Shalaka, Noronha, Jarin, Hawaldar, Rohini, Kundgulwar, Girish, Vanmali, Vaibhav, Parmar, Vani, Nair, Nita, Shet, Tanuja, Badwe, Rajendra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2019
Materias:	Original Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426546/ https://www.ncbi.nlm.nih.gov/pubmed/30811304 http://dx.doi.org/10.1200/JGO.18.00165

Ejemplares similares

Sterilization Rate of the Axilla After Neoadjuvant Chemotherapy: The Scope for Conservative Surgery
por: Noronha, Jarin, et al.
Publicado: (2020)

Sentinel Node Biopsy Versus Low Axillary Sampling in Predicting Nodal Status of Postchemotherapy Axilla in Women With Breast Cancer
por: Parmar, Vani, et al.
Publicado: (2020)

Effectiveness of a Decision Aid Plus Standard Care in Surgical Management Among Patients With Early Breast Cancer: A Randomized Clinical Trial
por: Joshi, Shalaka, et al.
Publicado: (2023)

Awareness and Acceptability of Breast Reconstruction Among Women With Breast Cancer: A Prospective Survey
por: Nair, Nita S., et al.
Publicado: (2021)

Micrometastases in axillary nodes: Out of the reckoning?
por: Singh, Akshita, et al.
Publicado: (2016)

Outcomes of non-metastatic triple negative breast cancers: Real-world data from a large Indian cohort
por: Bajpai, Jyoti, et al.
Publicado: (2022)

Should molecular subtype be recommended as one of the selection criteria for accelerated partial breast irradiation? Preliminary results from an Asian cohort
por: Wadasadawala, Tabassum, et al.
Publicado: (2018)

Clinical Profile and Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer With Brain Metastases: Real-World Experience
por: Bhargava, Prabhat, et al.
Publicado: (2022)

Axillary lymph node dissection on the run?
por: Maeseele, N, et al.
Publicado: (2017)

Fibromatosis-like carcinoma-an unusual phenotype of a metaplastic breast tumor associated with a micropapilloma
por: Rekhi, Bharat, et al.
Publicado: (2007)

Unique challenges and outcomes of young women with breast cancers from a tertiary care cancer centre in India
por: Bajpai, Jyoti, et al.
Publicado: (2021)

Can targeted axillary dissection reliably advise de-escalation of completion axillary lymph node dissection?
por: Owusu-Brackett, Nicci, et al.
Publicado: (2023)

Pregnancy associated breast cancer (PABC): Report from a gestational cancer registry from a tertiary cancer care centre, India
por: Bajpai, Jyoti, et al.
Publicado: (2021)

Axillary Dissection Versus No Axillary Dissection in Elderly Patients with Breast Cancer and No Palpable Axillary Nodes: Results After 15 Years of Follow-Up
por: Martelli, Gabriele, et al.
Publicado: (2010)

Hyperechoic Lesions on Breast Ultrasound: All Things Bright and Beautiful?
por: Ramani, S. K., et al.
Publicado: (2021)

Axillary lymph node dissection: Dead or still alive?
por: Beck, Anna C., et al.
Publicado: (2023)

In Defense of Merit to Overcome Merit
por: Daraio, Cinzia
Publicado: (2021)

Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level
por: Yuan, Qianqian, et al.
Publicado: (2021)

Activation of phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin pathway and response to everolimus in endocrine receptor-positive metastatic breast cancer – A retrospective pilot analysis and viewpoint
por: Bajpai, Jyoti, et al.
Publicado: (2017)

Imaging of the treated breast post breast conservation surgery/oncoplasty: Pictorial review
por: Ramani, Subhash K, et al.
Publicado: (2017)

Pilomatrix Carcinoma Masquerading as Breast Carcinoma
por: Pai, Trupti, et al.
Publicado: (2017)

Excellent response to erlotinib in breast carcinoma with rare EGFR mutation—a case report
por: Singh, Gunjesh Kumar, et al.
Publicado: (2020)

Radiotherapy instead of axillary lymph node dissection: evaluation of axillary lymph node dose coverage with whole breast radiotherapy
por: Bukovszky, Bence, et al.
Publicado: (2022)

Dissection of Level III Axillary Lymph Nodes in Breast Cancer
por: Hu, Jiejie, et al.
Publicado: (2021)

Breast cancer: An overview of published Indian data
por: Rangarajan, Bharath, et al.
Publicado: (2016)

Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
por: Choi, Hee Jun, et al.
Publicado: (2022)

Axillary recurrences after sentinel node (SLN) biopsy without complete axillary dissection in breast cancer patients
por: Kristen, P, et al.
Publicado: (2005)

Comparison of indocyanine green and methylene blue use for axillary reverse mapping during axillary lymph node dissection
por: Wu, Jun‐Dong, et al.
Publicado: (2020)

Axillary lymph node dissection for breast cancer utilizing Harmonic Focus(®)
por: Ostapoff, Katherine T, et al.
Publicado: (2011)

Idiopathic Thrombocytopenic Purpura after Mastectomy and Axillary Lymph Node Dissection
por: Santivasi, Wil L., et al.
Publicado: (2014)

Axillary Lymph Node Dissection in Angiosarcomas of the Breast: An Asian Institutional Perspective
por: Ragavan, Sharanniyan, et al.
Publicado: (2020)

Evaluation of the impact of the COVID-19 pandemic on the practice of axillary node dissection
por: Harris, G.A., et al.
Publicado: (2021)

Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai
por: Mittra, Indraneel, et al.
Publicado: (2021)

Reply: Axillary recurrences after sentinel node (SLN) biopsy without complete axillary dissection in breast cancer patients
por: Reitsamer, R, et al.
Publicado: (2005)

Can axillary radiotherapy replace axillary dissection for patients with positive sentinel nodes? A systematic review and meta-analysis
por: Zhao, Min, et al.
Publicado: (2017)

Axillary Reverse Mapping in Patients Undergoing Axillary Lymph Node Dissection: A Single Institution Experience From India
por: Jena, Sanghamitra, et al.
Publicado: (2021)

Videoendoscopic single-port axillary dissection
por: Uras, Cihan, et al.
Publicado: (2011)

Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the SERC trial: axillary dissection versus no axillary dissection in patients with involved sentinel node
por: Houvenaeghel, Gilles, et al.
Publicado: (2018)

200 Sentinel lymph node biopsies without axillary lymph node dissection – no axillary recurrences after a 3-year follow-up
por: Reitsamer, R, et al.
Publicado: (2004)

Morbidity after conventional dissection of axillary lymph nodes in breast cancer patients
por: Soares, Emerson Wander Silva, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ks97gmci1bn74r893cjt1udua8